Pentasa 2g Deposito-Granulat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pentasa 2g deposito-granulat

ferring ag - mesalazinum - deposito-granulat - mesalazinum 2 g, povidonum, ethylcellulosum, ad granulatum pro charta. - la colite ulcerosa - synthetika

Pentasa Suppositorien Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pentasa suppositorien

ferring ag - mesalazinum - suppositorien - mesalazinum 1 g, povidonum, macrogolum 6000, magnesio stearas, talco, per suppositorio. - trattamento attivo ulcerative proctite - synthetika

Salofalk 500 mg Granulat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salofalk 500 mg granulat

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 500 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 1 mg, ad granulatum, pro charta 930 mg corresp. natrium 1.62 mg. - la colite ulcerosa - synthetika

Salofalk 1000 mg Granulat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salofalk 1000 mg granulat

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 2 mg, ad granulatum, pro charta 1.86 g corresp. natrium 3.24 mg. - la colite ulcerosa - synthetika

Salofalk 1.5 g Granulat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salofalk 1.5 g granulat

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1.5 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 3 mg, ad granulatum, pro charta 2.79 g corresp. natrium 4.86 mg. - la colite ulcerosa - synthetika

Salofalk 3 g Granulat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salofalk 3 g granulat

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 3000 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum, e 171, aromatica (vanille-creme), aspartamum 6 mg, ad granulatum, pro charta 5.58 g corresp. natrium 9.72 mg. - la colite ulcerosa - synthetika

Salofalk 1000 mg Rektalschaum Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salofalk 1000 mg rektalschaum

dr. falk pharma ag - mesalazinum - rektalschaum - mesalazinum 1000 mg, polysorbatum 60, alcohol cetylicus et stearylicus 9.1 mg, dinatrii edetas, propylenglycolum 3436 mg, e 223, nitrogenium, propanum et butanum et isobutanum, propellentia et ad suspensionem pro dosi. - la colite ulcerosa - synthetika

Puri-Nethol Compresse Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

puri-nethol compresse

aspen pharma schweiz gmbh - mercaptopurinum monohydricum - compresse - mercaptopurinum monohydricum 50 mg, excipiens pro compresso. - farmaco - synthetika

Xaluprine 20 mg/ml Sospensione orale Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

xaluprine 20 mg/ml sospensione orale

lipomed ag - mercaptopurinum monohydricum - sospensione orale - mercaptopurinum monohydricum 20 mg, xanthani gummi, aspartamum 3 mg, rubi idaei succus concentratus cum saccharum max. 32 mg et e 220 max. 0.24 mg, e 219 1.15 mg, e 215 0.57 mg, e 202, natrii hydroxidum, aqua purificata ad suspensionem pro 1 ml corresp. natrium max. 0.68 mg. - farmaco - synthetika

AZAFOR Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

azafor

alfasigma s.p.a. - azatioprina - azatioprina